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1. Introduction
Certain creatures possess the properties of eternal youth and deathlessness. These include
Turritopsis (a species of small jellyfish) and planarians. Old Turritopsis starts a degenera‐
tion to transform into polyps and thereby achieves a perpetual life cycle [1]. The old cells
contained in an old imago change into young cells when the imago transforms into a polyp.
The polyp then starts to grow until it reaches the imago stage. As the Turritopsis can repeat
this cycle forever, it can be considered to exist in a state of deathlessness. Planarians possess
a special property of not growing older. They contain numerous stem cells throughout their
bodies and every portion of their body can reproduce [2]. Planarians may therefore be an
ageless organism. The property of agelessness is also present in humans. The case of Brooke
Greenberg, an American woman who could not grow older after developing highlander
syndrome, was the subject of a number of news reports in Japan a few years ago [3]. More‐
over, there are several reported cases of female patients who developed highlander syn‐
drome; however, the veracity of these reports is unclear, and the gene that causes the syndrome
has not been elucidated. The development of highlander syndrome in human patients suggests
that humans might possess the genes that enable the property of eternal youth.
The actualization of eternal youth is a long-held dream, and numerous studies have been
performed to elucidate the mechanisms of aging and to achieve eternal youth. Consequently,
recent studies have partially elucidated the process of aging and proposed several anti-aging
or rejuvenation procedures; however, the studies are currently in the middle stage, and the key
elements of the aging process have yet to be elucidated. The purpose of this chapter is to
present an overview of the recent topics on cellular aging and rejuvenation to provide an
outline of the content in this book. This chapter also complements the chapters that follow; in
which researchers introduce topics related to aging and rejuvenation.
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided the original work is properly cited.
2. The mechanisms of cellular aging
2.1. Aging by telomere shortening
Cultured human cells become older through repeated cell division. Cells eventually stop
dividing when they reach the critical passage number, the Hayflick limit [4]. Blackburn [5] and
Greider discovered that the telomeres function as a clock by marking the passage of time in
cells. The molecular mechanism of aging, which is described below [6–8], was elucidated
through this discovery.
RNA primer is degraded and exchanged to DNA with DNA polymerase I followed by
replication with DNA polymerase III. However, the RNA primer present at the terminal
portion of telomeres cannot be exchanged to DNA. As a result, approximately 100 sequence
bases are shortened in every replication. The shortening of telomeres acts as a fuse and decides
the limit of cell division. The length limit (M1 period) in human fibroblasts is approximately
5 kb, but most cells in elderly humans do not reach the M1 period [9]. Moreover, mouse
telomeres are of sufficient length, even in old mice, due to the expression of telomerase.
Otherwise, cells in the M1 period can continue to undergo cell division by transforming with
T antigen [10]. In such cells, the shortening of telomeres continues, and cell division is finally
stopped again by the fusion of mutual terminals (the M2 period) or apoptosis. Telomeres are
therefore protected from further shortening by a safe limit (the M1 period).
The pathway from telomere shortening to the cessation of cell division has also been elucidated
[7]. A telomere is formed by both double-stranded DNA, which is made by repeated sequences
(“TTAGGG” in the mammals), and single-strand DNA (G-tail) of similar sequences that exist
at the terminal portion. A telomere has to construct the T-rope structure to avoid degradation
by DNA degrading enzymes. This structure gives the first signal to initiate the progression of
cell division. The shortening of telomeres causes the obstruction of the T-rope structure and
signals certain proteins, including telomeric repeat-binding factor 2 (TRF2), AMP kinase and
histone deacetylase, to delay or stop cell division. The detection of the signal by AMP kinase
activates p53 and/or p21 proteins and inhibits the work of the cyclin-dependent kinase (CDK)
complex. Finally, the inhibition of the CDK complex causes cell division to stop at the Go
period, because CDK is a control switch that determines whether cell division should be
promoted.
2.2. The effects of mitochondria on the aging process
Mitochondria also have a role in the aging process [11, 12]. Mitochondria produce ATP using
the electron transport chain pathway where reactive oxygen species (hydrogen peroxide,
hydroxyl radical and hydroperoxyl radical) are produced. Reactive oxygen species are often
leaked through the mitochondrial inner membrane, damage DNA, proteins, and lipids. It has
been confirmed by the experiments with nematodes [13] that reactive oxygen species promote
aging. For instance, the mutation of the mev-1 gene in nematodes was found to result in a
shorter life span, because the gene disruption caused a defect in the electron transport chain
and an increase in the level of reactive oxygen species. Conversely, a mutation of the age-1
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gene in nematodes caused the enhancement of catalase activity which degraded hydrogen
peroxide and resulted in a prolonged life span.
Recent studies have suggested an interaction between mitochondrial dysfunction and
telomere shortening because of the following process [12, 14, 15]. The shortening of telomeres
causes the activation of the p53 protein, the activation of which inhibits the activities of
PGC-1α and β, which induce the activation of mitochondria. This inhibition finally causes a
decrease in many important mitochondrial activities and the progression of the aging process.
On the contrary, an increase in the level of active oxygen species due to mitochondrial
dysfunction often causes the oxidation of telomeres; the numerous guanine repeats on
telomeres cause them to react easily with oxygen. In telomere DNA, oxidation disturbs the
combination of TRF2 with telomere DNAs and the normal T-rope structure, which is the first
signal that cell division cannot proceed. Thus, under high concentrations oxygen, the telomeres
in human cells are rapidly shortened and cell growth is inhibited.
2.3. The factors promoting the aging process
Studies using both old cells (M1 period) and young cells (Low PDL) have suggested other
causes of the aging. When cell fusion occurs between a young cell and an old cell from which
the nucleus has been removed, the cell division of the fused cell is inhibited. However, when
old cells that were previously treated with a protein synthesis inhibitor are used, growth is not
inhibited. Moreover, when the cell membrane of old cells or mRNAs of cells stopped at the Go
period, respectively, are injected into younger cells, cell division stops or DNA replication is
inhibited. These results suggest that some proteins, mRNAs and/or cell membranes that are
present in older cells gradually accumulate with every cell division and promote the aging
process. The genes corresponding to such compounds have also been screened [16, 17]. Some
genes (gas, gadd, mot1, and hic-5) have been cloned. Unfortunately, they were not the most
important genes for controlling the aging process. Recently screening has been performed
using RNA, and some promising genes have been identified [18, 19].
2.4. The genes associated with premature senility syndromes
Information that is important for elucidating the aging process in humans can be obtained
from the genes that cause premature senility syndrome. Five types of helicases (RecQL1, BLM,
WRN RecQL4/RTS, and RecQL5) that untangle DNA chains exist in humans. The change of
the proteins to abnormal sequences causes premature senility syndromes [20]. Werner, Bloom,
and Rothmund–Thomson syndromes are caused by abnormal structures of the WRN, BLM,
and RecQL4/RT proteins, respectively. The WRN protein, which is related to the replication,
restoration, transcription, and stabilization of DNA or telomeres, is remarkable. In the case of
patients of Werner syndrome, the onset of symptoms occurs after patients stop growing at
approximately 10 years of age. In Werner syndrome, the aging process advances much faster
than in normal individuals. Patients show normal nerve and immune systems but possess
unusual chromosomes. The WRN gene was expected to become a target of aging in normal
individuals, because with the exception of the speed at which aging advances, the symptoms
are similar to the normal aging process. However, WRN knockout mice do not show premature
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senility syndrome, whereas WRN and TERC knockout mice do [21]. Further investigation is
necessary to improve our understanding of the relationship between WRN and the aging
process.
The other remarkable premature senility syndrome is Hutchinson–Gilford progeria syndrome
(HGPS), which is caused by partial loss of the lamin A protein [22]. HGPS patients are normal
at birth. HGPS develops at 6–18 months of age; the average life span of an HGPS patient is
13 years. Lamin A exists inside a nuclear membrane and supports the structure of the
membrane. It is changed to a farnesylated version to perform nuclear translocation, and
farnesylated lamin A is related to both the replication and transcription of DNA and signal
transduction. The unusual farnesylated lamin A that is found in HGPS patients is called
“progerin” [23]. Progerin accumulates and inhibits translocation, and the inhibition causes the
aging of cells. In normal individuals, progerin gradually accumulates in the skin cells due to
aging. Progerin is therefore a target of treatments to delay the aging process.
3. Realizing cellular rejuvenation
3.1. Rejuvenation by telomerase activation
In humans, although telomerase can make telomeres longer, most types of cells (including
fibroblasts, spanchnic cells, and nerve cells) show very low telomerase activity [24]. In contrast,
germ and cancer cells, which actively perform cell division, show high telomerase activity and
long telomeres. This suggests that the cells may be rejuvenated if telomerase can be activated
[25–27].
Studies on the fibroblasts and mice that express telomerase reverse transcriptase (TERT) gene
by transformation have supported this hypothesis [28–30]. For example, a human OSMU36-
T2 fibroblast showing high telomerase activity was obtained by transforming the TERT gene
into an OSMU36 fibroblast. The telomere length and the telomerase activity of OSMU36-T2
were several times higher than those observed in OSMU36 fibroblast, and many characteristics
including the cell size, growth rate, and gene expression were similar to those observed in
young fibroblasts [28]. Moreover, the life span of a TERT knockout mouse, which was
produced by Harvard University, was much shorter (only 6 months) than normal mice due to
the rapid shortening of the telomeres. When telomerase was activated in the knockout mice,
neurons were formed and rejuvenation was found in some portions [29, 30]. Thus, it may be
possible to initiate cellular rejuvenation in individuals as well as cultured cells through the
activation of telomerase.
Telomerase activity and telomere length are affected by lifestyle [31, 32]. Researchers at
California University group examined the effects of food, exercise, and psychological stress
on the telomere length in 35 males [31]. The members of one group continued to consume
vegetables as a staple food, to perform adequate exercise and to decrease psychological stress
through self-control for 5 years. As a result, their telomeres were longer than the members of
the control group. Other researchers investigated the effects of exercise. The results suggested
that the athletes who ran more than 40 km every day were 16 years younger in telomere length.
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Moreover, telomerase can be activated by some chemical compounds, which are expected to
have applications as rejuvenation drugs. For instance, the rate at which telomeres shorten is
accelerated by high serum concentrations of cholesterol, because cholesterol hastens cell
division. Thus, mononucleosis patients who continuously took statin (an anticholesteremic
agent) showed higher telomerase activity and longer telomeres than the patients who did not
take statin [33]. Several years ago, a compound named TA-65, which was isolated from the
root of the Hedysarum, was screened as a telomerase activating compound [34], and the
rejuvenation effect of TA-65 was examined in mice.
As telomerase activity can be controlled by lifestyle and some compounds, the enhancement
of telomerase activity may become an effective treatment to promote cellular rejuvenation.
However, the enhancement of telomerase activity may also cause the activation or induction
of cancer cells, because high telomerase activity is one of the characteristics of cancer cells [35–
37]. Further studies to determine whether the activation of telomerase can truly induce a
rejuvenation condition without the risk of cancer cell activation will be necessary before it can
be used in supplements and drugs.
3.2. Rejuvenation by antioxidants
Leucocytes secrete reactive oxygen species to protect against psychological stress in social life
or physical stresses including atmospheric pollutants, UV, and viruses. The excessive produc‐
tion of reactive oxygen species promotes aging (as described in Section 2.2.). Although catalase,
superoxide dismutase (SOD), and glutathione peroxydase can remove such reactive oxygen
species in humans, catalase, and SOD activities gradually decrease due to aging. Thus, reactive
oxygen species cannot be sufficiently removed in elderly individuals. In other words, the aging
process can be delayed or remediated if the excessive production of reactive oxygen species is
prevented.
Antioxidants, such as vitamins and polyphenols, are effective in removing active oxygen
species, and their anti-aging effects have been studied for many years [38, 39]. The studies
suggest that the oxidation of cultured cells can be inhibited by antioxidants and that mice that
continuously took antioxidants showed lower oxidation and a longer life span than controls.
Recent studies in humans, however, suggested that the anti-aging effects are doubtful. For
example, in experiments in which healthy human subjects took β-carotene or vitamins for a
long period of time, the ratio of depth was not decreased. Certain amounts or components of
antioxidants may be required to make the effects of antioxidants prominent in humans.
3.3. Rejuvenation by anti-aging hormones
Anti-aging hormones have remarkable potential as anti-aging or rejuvenation treatments.
There are several candidate compounds, including klotho, sirtuin, Bach1, Clk-1, and polya‐
mines [40–46]. The klotho gene is mainly expressed in the nervous system to control the
calcium concentration in blood; klotho works as a controller of homeostasis, although the
precise work of the protein has not been sufficiently elucidated [40, 41]. Klotho knockout mice
develop many symptoms related to aging, such as arteriosclerosis, osteoporosis, motor
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impairment and have a shortened life span. Conversely, klotho knock-in mice have a life span
that is several years longer [42]. Thus, klotho is a promising target in rejuvenation.
Histone deacetylases (sirtuin) is another candidate protein [43, 44]. Sirtuin works as an energy
economizing hormone to prolong the life span. Sirtuin 1, 6 and 7 knockout mice showed faster
aging and a shorter life span. Hibernation, which represents a state of extreme energy
limitation, extended the life spans of yeasts, rematodes, and mice. One reason for the prolon‐
gation of the life span is that the amount of excess active oxygen is decreased by the energy
limitation; thus, the promotion of the aging process by undesirable oxidation is inhibited.
Another cause is the activity of sirtuin. Sirtuin 2 is activated by the decrease of NAD, which is
caused by energy limitation. The activation of sirtuin 2 increases the deacetylation of histones
to silence the genes, and the economizing of energy prolongs life span.
The following monkey experiments were performed to estimate the action of sirtuin in relation
to energy limitation. The Wisconsin National Primate Research Center examined the effects of
calorie restriction on 76 rhesus monkeys. The monkeys that had were fed low-calorie food (a
30% calorie reduction) looked much younger and showed a longer life span than control
members (100% calorie) [47]. However, a similar experiment by the NIA in the United States
in 2012 suggested the reverse results [48]. Therefore, further discussion is necessary to confirm
the relationship between anti-aging and energy limitation.
Resveratrol has been screened as a compound that is effective for enhancing the expression of
the sirtuin gene [49]. When resveratrol was given to mice that had been fed a high-calorie diet,
some of the factors of aging were inhibited, and the activities of AMPK and PGC-1α were
enhanced; however, the anti-aging were insufficient. If compounds that can more effectively
enhance the sirtuin gene are discovered, they will become a prominent anti-aging hormone.
Polyamines also show remarkable characteristics. Polyamines, such as spermine, spermidine,
and putrescine, are essential for the growth of mammals and play important roles in cell
division and differentiation; however, their precise action has not been sufficiently elucidated
[50, 51]. In most cells of the human body, the concentrations are maintained at low levels. They
are only found at high levels in cells that are actively working, such as testicular cells and
cancer cells. The amounts of polyamines in those cells are especially increased before DNA
synthesis; the growth rate in cancer cells increases in proportion to the amount of polyamine
that is added to the medium. Polyamines are therefore related to the activation of cells.
Some studies suggest that polyamines function as an anti-aging hormone. The addition of
polyamines to fibroblasts enhanced the expression of genes related to aging [20], and mice that
were contentiously fed a diet containing a high concentration of polyamine appeared much
younger and had a longer life span than mice that were fed a diet without polyamine [52].
Other researchers, who had studied the relationship between Lactobacillus bifidus and life span,
suggested that the life span of mice was prolonged by the polyamines that were produced by
L. bifidus cells [53, 54]. The amounts of spermine and spermidine in humans gradually decrease
due to aging, and the concentration of polyamines in the blood can easily be increased by eating
foods, such as soy beans. Thus, polyamines may also be useful as supplements for anti-aging
or rejuvenation.
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4. Conclusion
In this chapter, the author focused on cellular aging and rejuvenation. Recent studies have
gradually elucidated the aging process and have suggested that telomerase, the mitochondria
and other components (RNAs and proteins) are involved in the aging process. However, these
studies are ongoing. Moreover, studies on the aging process have identified several anti-aging
compounds that can activate telomerase (TA-65), inactivate reactive oxygen species (anti-
oxidants) and work as anti-aging hormones (klotho, sirtuin, resveratrol, and polyamine). In
the near future, these compounds and/or other compounds with greater effects may become
prominent drugs for anti-aging and rejuvenation.
Research into regeneration with the use of iPS cells is recently showing remarkable progress.
Although the topic was not introduced in this chapter, the regeneration of cutaneous and nerve
tissues or internal organs using regeneration medicine will be another means of realizing
rejuvenation. Researchers studying anti-aging will have to watch the progress of both
regeneration medicine and cellular rejuvenation research.
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